ArticleBMC infectious diseases2026
Performance of the French national hospital discharge database algorithm to identify hospitalised Lyme borreliosis cases, France, 2017-2018.
Article in BMC infectious diseases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundIn France, surveillance of Lyme borreliosis (LB) is based on general practitioners of a sentinel network and the national hospital discharge database (PMSI). Given the known limitations of the PMSI for epidemiological surveillance, we assessed the performance of its algorithm in identifying hospitalised LB cases in three university hospitals, in terms of sensitivity and positive predictive value (PPV).
methodsWe identified patients hospitalised during 2017-2018 with positive laboratory results for LB from hospital laboratory databases. Simultaneously, we screened in the PMSI LB hospitalised patients via the algorithm based on ICD-10 codes. Classifications were made by applying the EUCALB criteria. Confirmed and probable LB cases were classified as "LB+". We then calculated sensitivity (proportion of LB+ hospitalised cases identified by the PMSI algorithm) and PPV (proportion of LB+ cases among patients identified as LB by the PMSI algorithm).
resultsAmong 541 patients with positive laboratory results, 54 were classified as LB+. The PMSI identified 62 cases, of which 38 were LB+. Overall sensitivity was 62%, varying by site (40-79%). Sensitivity was highest for paediatric cases (83%), Lyme arthritis (83%), and neuroborreliosis ( 61%). PPV was 61%, reaching 96% for neuroborreliosis and 83% for Lyme arthritis.
conclusionThe PMSI algorithm showed moderate sensitivity and PPV for identifying hospitalised LB cases, with higher performance for neuroborreliosis and Lyme arthritis. Our findings support focusing PMSI-based surveillance on neuroborreliosis and arthritis. Improvement of the PMSI algorithm is necessary but it remains a valid tool for assessing the burden and trends over time at the national and regional levels.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.